Becton Dickinson, and Company (NYSE:BDX) lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday. The medical device company reported adjusted earnings per share of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results